Navigation Links
Finding Cures For Tropical Diseases: Is Open Source An Answer?

There's a paradigm in life science and drug development : only "lucrative" "markets" get exploited by R&D companies. In many occasions I've seen very promising drugs candidates or related research get canned because no money was to be made with it, even if millions would have been saved worldwide. The usual strategy to avoid this fate is to find a drug candidate that affect a "profitable" disease in addition to the "non-profitable" one. PLoS Medecine has an article about a possible solution titled "Finding Cures for Tropical Diseases: Is Open Source an Answer?" The whole article is a very good read; a summary from ScienceDaily is available in the full post.

Only about 1% of newly developed drugs are for tropical diseases, such as African sleeping sickness and dengue fever. While patent incentives have driven commercial pharmaceutical companies to make Western health care the envy of the world, the commercial model only works if companies can sell enough patented products to cover their R&D costs and produce profits for shareholders. The model thus fails in the developing world, where few patients can afford to pay patented prices for drugs. The solution to this devastating problem, say Stephen Maurer, Arti Rai, and Andrej Sali in the premier open-access medical journal PLoS Medicine, is to adopt an "open source" approach to discovering new drugs for neglected diseases. They call their approach the Tropical Diseases Initiative (www.tropicaldisease.org), or TDI. "We envisage TDI as a decentralized, Web-based, community-wide effort where scientists from laboratories, universities, institutes, and corporations can work together for a common cause." What would open-source drug discovery look like? "As with current software colla
'"/>

Source:Science Daily, PLoS Medecine


Page: 1 2

Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. Findings have implications for tracking disease, drugs at the molecular level
3. Finding hidden invaders in a Hawaiian rain forest
4. New Finding May Aid Adult Stem Cell Collection
5. Finding rewrites the evolutionary history of the origin of potatoes
6. Finding the minds eye
7. Findings advance use of adult stem cells for replacement bone
8. Finding a virus is not all bad news
9. Finding a better way to make biodiesel
10. Finding paves way for better treatment of autoimmune disease
11. Finding the right mix: A biomaterial blend library

Post Your Comments:
(Date:11/20/2009)... study, researchers report that a class of heart m..., or harmful, effect on the heart, depending on th...rs in the journal Circulation Research , found th...eta-receptors on the heart muscle offer the most b...t only the beta-receptors can actually undermine t...
(Date:11/19/2009)...tists are revealing the genetic instructions insid...r maize, has one of the most complex sequences of ...dison genomicist David Schwartz, who was one of mo... Science . , "The maize genome is a true maze f...roubled would-be sequencers for years," says Schwa...
(Date:11/19/2009)...netic diversity in maize, also known as corn, rese... gene map that should pave the way to significant ...food, fuel, animal feed and fiber around the world...n as a haplotype map, charts genetic diversity and...s of maize. The research team, led by U.S. Departm...
Breaking Biology News(10 mins):Carvedilol shown to have unique characteristics among beta blockers 2Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 1Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 2Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 3Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 4Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 5Premiere Fibers Unveils New Logo Names for Innovative Brands 49074 1Premiere Fibers Unveils New Logo Names for Innovative Brands 49074 2Patient Centered Primary Care Collaborative Stakeholders Come to Washington DC for July Working Meeting 49072 1Patient Centered Primary Care Collaborative Stakeholders Come to Washington DC for July Working Meeting 49072 2Patient Centered Primary Care Collaborative Stakeholders Come to Washington DC for July Working Meeting 49072 3
...INGTON, DC--Construction of new coal-fired power p...to a standstill, partly due to the high cost of th... capture all emissions of carbon dioxide, an impor...an intermediate step that could get construction m...ng electricity shortages using our most-abundant, ...
...USTON -- (Nov. 17, 2008) -- A "chip" or array that...e or other diseases associated with chromosomal ab...iagnosis in a series of 300 cases at Baylor Colleg...ppears in the current issue of the journal Prenat... Arthur Beaudet and Dr. Sau Wai Cheung at BCM, des...
...MBUS, Ohio Scientists have identified a relations...ks to both nicotine addiction and autism. The find...d to curb nicotine addiction might serve as the ba...oms of autism. , The discovery identified a defin..., which is located in brain cells and assists in c...
Other Biology News:MIT: A quicker, easier way to make coal cleaner 2MIT: A quicker, easier way to make coal cleaner 3Microarray analysis improves prenatal diagnosis 2Microarray analysis improves prenatal diagnosis 3Researchers find link between nicotine addiction and autism 2Researchers find link between nicotine addiction and autism 3
(Date:11/19/2009)...ewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: N...ng letter to its shareholders, discussing the Comp...iopharmaceuticals Holdings, Inc. (CHBP), an integr...e,s Republic of China. The merger gives NeoStem a ...ical Co. Ltd., CHBP,s primary operating subsidiary...
(Date:11/19/2009)...ALTHAM, Mass., Nov. 19 Arlington M... that the leading driver of antibiotic selection i... activity against gram-positive and gram-negative ...n cause nosocomial pneumonia, surveyed European ph...s that provide appropriate coverage against common...
(Date:11/19/2009)...ewswire/ - Aegera Therapeutics Inc. announced toda...Phase 2B study of AEG35156, a targeted antisense t...ncology indications. ,, The study, entitled "An...ed Inhibitor of Apoptosis (XIAP) Antisense AEG3515...nd Idarubicin in AML Following Failure of a Single...
(Date:11/19/2009)... Top Gene Synthesis Companies Form International G... Practices in Risk Reduction ,Five Member Compan...is Capacity , (PRWEB) Nov...g gene synthesis companies today announced agreeme...l to promote biosecurity in the gene synthesis ind...
Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...plications for OB/GYN, NEW ORLEANS, May 3 Siemen... highlights new products and solutions (booth,#102...ians and,Gynecologists Annual Meeting in New Orlea...bin/prnh/20070904/SIEMENSLOGO ), The latest memb...CUSON,S2000(TM) ultrasound system, provides excell...
...poration,(Nasdaq: BPUR ) today announced that a m...lthcare Products Regulatory Agency (MHRA) is sched...the meeting is to clarify the issues outlined in a...ited Kingdom,s Commission,on Human Medicines regar...rization for Hemopure(R). The issues relate to qua...
...Hutchinson Cancer,Research Center have a lead role... first systematic surveillance program of men with...elp determine when to wait and when,to treat the d...undation,and the National Cancer Institute., Pete...l Research and,Human Biology divisions, will lead ...
Other Biology Technology:Siemens Showcases New ACUSON S2000 Ultrasound System, as Well as World's First Pocket Ultrasound System 2Siemens Showcases New ACUSON S2000 Ultrasound System, as Well as World's First Pocket Ultrasound System 3Biopure Announces Date to Meet with UK's Medicines and Healthcare Products Agency 2Biopure Announces Date to Meet with UK's Medicines and Healthcare Products Agency 3When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer 2When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer 3
...MAT IS, a true benchtop incubator-shaker, has the ...s. Having a footprint of 540 x 680 mm (W x D) doe... 505 x 510mm). Available in 25 mm or 50 mm orbits,... requiring controlled speed and temperature Anal...
...00 is one of the smallest thermal cyclers on the m...the 0.5ml (20 samples) or 0.2ml microtube (25 samp...oling rate of 3.6C/sec and 2.0C/sec respectively ...rack programming with new quick dial facility Bu...
...e HRP Conjugate Stabilizer is an aqueous solution ...non-toxic stabilizing chemicals in a MOPS buffer (...7. This product contains a combination of 0.02% m... ppm Proclin 300 (Rohm and Haas Company) as a pres...
Ribonucleic acid, transfer, phenylalanine specific from brewer's yeast from Sigma-Aldrich
Biology Products: